Pharmacy alerts

Baxter Healthcare Corporation, Onkotrone Injection 2 mg/ml concentrate for solution for infusion defect

Class 4 medicines defect notification: The MHRA has published a Class 4 medicines defect notification for Onkotrone Injection 2 mg/ml concentrate for solution for infusion.

Rokshaw Limited Trading as Curaleaf Laboratories, Curaleaf Oil [FS] 10mg/ml THC, 10mg/ml CBD (30ml) recalled

Class 2 medicines recall: The MHRA has published a Class 2 medicines recall for specific batches of Curaleaf Oil [FS] 10mg/ml THC 10mg/ml CBD (30ml).

Crescent Pharma Limited, Ramipril 5mg capsules recalled

Class 2 medicines recall: The MHRA has published a Class 2 medicines recall for Ramipril 5mg capsules.

Updated UKHSA Immunisation Training standards and Quality criteria

Updated UKHSA Immunisation Training standards and Quality criteria The UK Health Security Agency (UKHSA) has published updated guidance on National Minimum Standards and Core Curriculum for Vaccination Training. This document sets the standards and lists the essential topics which should be incorporated into immunisation training. UKHSA has also published updated guidance on Quality criteria for an effective immunisation programme which defines the key elements for the implementation and delivery of a safe, equitable, high quality, effective and efficient immunisation service. Both can also be found in the training resources section of the Immunisation collection page: Immunisation – GOV.UK. Date27 Jun 2025 AuthorAnonymous Tags

Rayner Pharmaceuticals Limited, Dropodex 0.1% w/v eye drops defect

Class 4 defect notification: The MHRA has published a Class 4 medicines defect notification for Dropodex 0.1% w/v eye drops.

Falsified Mounjaro KwikPen 15mg pre-filled pens found

Drug Safety Update: The MHRA has issued a Drug Safety Update for Mounjaro KwikPen 15mg pre-filled pens.